Vaccine-preventable diseases in Ecuador and Latinamerica: a Public Heatlh problem
DOI:
https://doi.org/10.31052/1853.1180.v29.n1.39725Keywords:
enfermedad prevenible por vacunación, Sudamérica, Tasas de vacunaciónAbstract
ntroduction: Current vaccination coverage rates in Latin America and the Caribbean (LAC) are lower than regional rates set by the Pan American Health Organization, and this has been further exacerbated by COVID-19 pandemic in the Americas during 2020 and 2021.
Objective: The objective of this study is to inform the medical community about the gap regarding coverage of immunizations for vaccine-preventable diseases in pediatric age groups in Latin America and the Caribbean.
Materials and methods: Various bibliographic sources were used obtained from search engines such as PubMed®, Scopus, and Google Scholar, using the following keywords and MeSH terms: "vaccine-preventable disease, South America, children, vaccine rates." PICO questions were formulated when looking for therapeutic studies using the Trip® search engine. Later, results were discriminated based on significance and the relevance of the article titles. A total of 206 studies were discarded completely, and 18 were selected, along with other 3 documents which were chosen to do this review article.
Results and conclusions: The pandemic has jeopardized the fulfilment of integrated surveillance indicators for measles/rubella and acute flaccid paralysis (AFP). Despite many victories in the region, Latin American vaccination policies have significant deficiencies, and more work is needed to keep the progress and to be prepared for the introduction of newly available vaccines.
A common regulatory framework for vaccine approval is needed to speed up delivery and bring together human, technological, and scientific resources in the region. These reforms are now crucial, particularly now that vaccines for previously neglected diseases in the developing world have become available.
Keywords: vaccine-preventable disease, South America, children, vaccination rates.
Downloads
References
Tapia R, Betancourt M, Saucedo R, Motta L, Gallardo H. Strengthening vaccination policies in Latin America: An evidence-based approach. Vaccine. 2013 Aug 20;31(37):3826-33. doi: 10.1016/j.vaccine.2012.12.062. Epub 2013 Jan 25.
Duclos P, Dumolard L, Abeysinghe N, Adjagba A, Bess C, et al. Progress in the establishment and strengthening of national immunization technical advisory groups: analysis from the 2013 WHO/UNICEF joint reporting form, data for 2012. Vaccine. 2013 Nov 4;31(46):5314-20. doi: 10.1016/j.vaccine.2013.08.084. Epub 2013 Sep 20.
Ulloa R, Miño G, Odio C, Ávila M, Brea J. Vaccine-preventable diseases and their impact on Latin American children, Expert Review of Vaccines, 10:12, 1671-1673, DOI: 10.1586/erv.11.153.
Soto C, García J, Molina J, Figueroa M, et al. Ministerio de Salud Pública y Asistencia Social. Protocolos de Vigilancia Epidemiológica de Enfermedades Inmunoprevenibles.
Ávila M, Beltrán S, Del Castillo J, Castillo M, Chaparro L, et al. Varicella epidemiology in Latin America and the Caribbean. Expert Rev Vaccines. 2018 Feb;17(2):175-183. doi: 10.1080/14760584.2018.1418327. 2017 Dec 29.
Gentile A, Paget J, Bellei N, Torres J, et al. Influenza in Latin America: A report from the Global Influenza Initiative (GII). Vaccine. 2019 May 6;37(20):2670-2678. doi: 10.1016/j.vaccine.2019.03.081. Epub 2019 Apr 8.
Gentile A, Bricks L, Avila-Agüero ML, Avila R, Torres JP, et al. Pertussis in Latin America and Hispanic Caribbean: a systematic review. Expert Rev Vacc 2019;18:829-45.
Principi N, Esposito S. Vaccine-preventable diseases, vaccines and Guillain-Barre' syndrome. Vaccine. 2019 Sep 3;37(37):5544-5550. doi: 10.1016/j.vaccine.2018.05.119. Epub 2018 Jun 4.
Haber P, Sejvar J, Mikaeloff Y, DeStefano F. Vaccines and Guillain-Barré síndrome. Drug Saf. 2009;32(4):309-23. doi: 10.2165/00002018-200932040-00005.
Hamilton J. Recognizing Vaccine-Preventable Diseases and Managing Outbreaks. Prim Care. 2020 Sep;47(3):467-481. doi: 10.1016/j.pop.2020.05.003. Epub 2020 May 22.
Guzmán A, DeAntonio R, Prado D, Juliao P. Barriers to vaccination in Latin America: A systematic literature review. Vaccine. 2020 Jan 16;38(3):470-481. doi: 10.1016/j.vaccine.2019.10.088. Epub 2019 Nov 22.
Aldaz P, Morató M, Gómez J, Javierre A, Martín S, et al. Prevención de las enfermedades infecciosas. Actualización PAPPS en vacunas 2018. 2018 May; 50(Suppl 1): 66–82. Published online 2018 Jun 1. Spanish. doi: 10.1016/S0212-6567(18)30363-9.
Hortal M, Di Fabio JL. Rechazo y gestión en vacunaciones: sus claroscuros. Rev Panam Salud Publica. 2019;43:e54. https:// doi.org/10.26633/RPSP.2019.54.
Su Qi-Ru, Yao Kai-Hu. Epidemiological and clinical features of vaccine-preventable diseases in vaccine era. Zhongguo Dang Dai Er Ke Za Zhi.2019 Mar;21(3):195-198. doi: 10.7499/j.issn.1008-8830.2019.03.001.
Pickering L, Baker C, Freed G, Gall S, et al. Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2009 Sep 15;49(6):817-40. doi: 10.1086/605430.
Phadke V, Bednarczyk R, Salmon D, Omer S. Association Between Vaccine Refusal and Vaccine-Preventable Diseases in the United States: A Review of Measles and Pertussis. JAMA. 2016 Mar 15;315(11):1149-58. doi: 10.1001/jama.2016.1353.
Porter A, Goldfarb A. Measles: A dangerous vaccine-preventable disease returns. Cleve Clin J Med. 2019 Jun;86(6):393-398. doi: 10.3949/ccjm.86a.19065.
Olusanya O, Bednarczyk R, David R, Shaban A. Addressing Parental Vaccine Hesitancy and Other Barriers to Childhood/Adolescent Vaccination Uptake During the Coronavirus (COVID-19) Pandemic. Front Immunol. 2021 Mar 18;12:663074. doi: 10.3389/fimmu.2021.663074. eCollection 2021.
PAHO. Vaccine-preventable diseases (diphtheria, measles, poliovirus) in the context of the COVID-19 pandemic: implications for the Region of the Americas.
PAHO. Report of the 20th Vaccination Week in the Americas. PAHO/FPL/IM/COVID-19/22-0048.
Ministerio de Salud Pública (MSP). Subsecretaría Nacional de Vigilancia de Salud Pública. (2022). Enfermedades Inmunoprevenibles SE 24 Ecuador 2022.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Escuela de Salud Pública y Ambiente. Facultad de Ciencias Médicas. Universidad Nacional de Córdoba
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License which allows the work to be copied, distributed, exhibited and interpreted as long as it is not done for commercial purposes.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) after the publication process. (See The Effect of Open Access). (See The Effect of Open Access).
How to Cite
